Pronuclear injection for the production of transgenic mice

Nature Protocols

Volumn 2, Issue 5, 2007, Pages 1206-1215

  Ittner, Lars M ^a   Götz, Jürgen ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA PURIFICATION; EMBRYO TRANSFER; FEMALE; GENETIC SCREENING; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECIPIENT; TECHNIQUE; TRANSGENIC MOUSE; TRANSGENICS; VASECTOMY; ZYGOTE;

ANIMALS; ANTIGENS, THY-1; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MICE; MICE, TRANSGENIC; MICROINJECTIONS; MODELS, ANIMAL; PROMOTER REGIONS (GENETICS); ZYGOTE INTRAFALLOPIAN TRANSFER;

MUS; MUS MUSCULUS;

EID: 34250219566     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2007.145     Document Type: Article

References (44)

1. Bryda, E.C., Pearson, M., Agca, Y. & Bauer, B.A. Method for detection and identification of multiple chromosomal integration sites in transgenic animals created with Lentivirus. Biotechniques 41 715-719 (2006).
2. Moreira, P.N., Pozueta, J., Giraldo, P., Gutierrez-Adan, A. & Montoliu, L. Generation of yeast artificial chromosome transgenic mice by intracytoplasmic sperm injection. Methods Mol. Biol. 349, 151-161 (2006).
3. Brinster, R.L., Chen, H.Y., Trumbauer, M.E. & Avarbock, M.R. Translation of globin messenger RNA by the mouse ovum. Nature 283, 499-501 (1980).
4. Gordon, J.W. & Ruddle, F.H. Integration and stable germ line transmission of genes injected into mouse pronuclei. Science 214, 1244-1246 (1981).
5. Brinster, R.L. et al. Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell 27, 223-231 (1981).
6. Costantini, F. & Lacy, E. Introduction of a rabbit beta-globin gene into the mouse germ line. Nature 294, 92-94 (1981).
7. Wagner, E.F., Stewart, T.A. & Mintz, B. The human beta-globin gene and a functional viral thymidine kinase gene in developing mice. Proc. Natl. Acad. Sci. USA 78, 5016-5020 (1981).
8. Wagner, T.E. et al. Microinjection of a rabbit beta-globin gene into zygotes and its subsequent expression in adult mice and their offspring. Proc. Natl. Acad. Sci. USA 78, 6376-6380 (1981).
9. Gotz, J., Probst, A., Ehler, E., Hemmings, B. & Kues, W. Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. Proc. Natl. Acad. Sci. USA 95, 12370-12375 (1998).
10. Tucker, K.L., Meyer, M. & Barde, Y.A. Neurotrophins are required for nerve growth during development. Nat. Neurosci. 4, 29-37 (2001).
11. Nagy, A., Gertsenstein, M., Vinterstein, K. & Behringer R. Manipulating the Mouse Embryo - A Laboratory Manual. 3rd edn. (Cold Spring Harbor Press, Cold Spring Harbor, New York, 2003).
12. Gotz, J. et al. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the Longest human brain tau isoform. EMBO J. 14, 1304-1313 (1995).
13. Rauer, M., Gotz, J., Schuppli, D., Staeheli, P. & Hausmann, J. Transgenic mice expressing the nucleoprotein of Borna disease virus in either neurons or astrocytes: Decreased susceptibility to homotypic infection and disease. J. Virol. 78, 3621-3632 (2004).
14. Kins, S. et al. Reduced PP2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. J. Biol. Chem. 276, 38193-38200 (2001).
15. Schild, A., Ittner, L.M. & Gotz, J. Altered phosphorylation of cytoskeletal proteins in mutant protein phosphatase 2A transgenic mice. Biochem. Biophys. Res. Commun. 343, 1171-1178 (2006).
16. Tam, C.W. et al. Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2. Circ. Res. 98, 262-270 (2006).
17. Gotz, J., Eibel, H. & Kohler, G. Non-tolerance and differential susceptibility to diabetes in transgenic: Mice expressing major histocompatibility class II genes on pancreatic beta cells. Eur. J. Immunol. 20, 1677-1683 (1990).
18. Schild, A. et al. Impaired development of the Harderian gland in mutant protein phosphatase 2A transgenic mice. Mech. Dev. 123 362-371 (2006).
19. Probst, A. et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol. (Berl) 99, 469-481 (2000).
20. Gotz, J. & Nitsch, R.M. Compartmentalized tau hyperphospholylation and increased levels of kinases in transgenic mice. Neuroreport 12 2007-2016 (2001).
21. Gotz, J. Tau and transgenic animal models. Brain Res. Brain Res. Rev. 35, 266-286 (2001).
22. Gotz, J. et al. Transgenic animal models of Alzheimer's disease and related disorders: Histopathology, behavior and therapy. Mol. Psychiatry 9, 664-683 (2004).
23. Feng, G. et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28, 41-51 (2000).
24. Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373 523-527 (1995).
25. Mucke, L. et al. High-Level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050-4058 (2000).
26. Hsiao, K. et al. Correlative memory deficits, abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
27. Borchelt, D.R. et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945 (1997).
28. Sturchler-Pierrat, C. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-Like pathology. Proc. Natl. Acad. Sci. USA 94, 13287-13292 (1997).
29. Oddo, S. et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles. Intracellular abeta and synaptic dysfunction. Neuron 39, 409-421 (2003).
30. Richards, J.G. et al. PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation. J. Neurosci. 23, 8989-9003 (2003).
31. Brion, J.P., Tremp, G. & Octave, J.N. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. Am. J. Pathol. 154, 255-270 (1999).
32. Ishihara, T. et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24, 751-762 (1999).
33. Lewis, J. et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402-405 (2000).
34. Gotz, J. et al. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau. Eur. J. Neurosci. 13, 2131-2140 (2001).
35. Spittaels, K. et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol. 155, 2153-2165 (1999).
36. Gotz, J., Chen, F., Barmettler, R. & Nitsch, R.M. Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 276, 529-534 (2001).
37. Allen, B. et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 22, 9340-9351 (2002).
38. Tanemura, K. et al. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau. Neurobiol. Dis. 8 1036-1045 (2001).
39. Tatebayashi, Y. et al. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc. Natl. Acad. Sci. USA 99, 13896-13901 (2002).
40. Andorfer, C. et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J. Neurochem. 86, 582-590 (2003).
41. Santacruz, K. et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476-481 (2005).
42. Andra, K. et al. Expression of APP in transgenic mice: A comparison of neuron-specific promoters. Neurobiol. Aging 17 183-190 (1996).
43. Truett, G.E. et al. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 29 52-54 (2000).
44. Chen, F., David, D., Ferrari, A. & Gotz, J. Posttranslational modifications of tau - role in human tauopathies and modeling in transgenic animals. Curr. Drug Targets 5, 503-515 (2004).